Research Groups and R&D Platforms: Autoimmune diseases

Research Group:
PET imaging of neuropathological changes in animal models of Alzheimer’s disease

Merja Haaparanta-Solin
mehaaso[at]utu.fi

Turku PET Centre, Preclinical Imaging,
University of Turku

Merja Haaparanta-Solin

Turku PET Centre

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Metabolic diseases, Nanoparticles, Neurological disorders, Organic compounds, PET, Pharmacology, Preclinical development, Receptor, Target discovery

Research Group:
Leukocyte traffic and the immune response

Marko Salmi
marko.salmi[at]utu.fi

Institute of Biomedicine
University of Turku

Marko Salmi

Autoimmune diseases, Basic research, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Imaging, Immunology, Inflammation, Next-generation sequencing, Receptor, Screening, Target discovery

Picture of Ilkka Julkunen

Research Group:
Innate and adaptive immunity in viral infections

Ilkka Julkunen
ilkka.julkunen[at]utu.fi

Institute of Biomedicine
University of Turku

Ilkka Julkunen

Antibodies, Assay development, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biotechnology, Diagnostics, Imaging, Imaging software, Immunology, In Vitro Diagnostics, Infection, Inflammation, Medicinal chemistry, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, Molecular modelling, Neurological disorders, Pattern recognition, Proteomics, Receptor, Signaling, Virology

Picture of Olli Pentikäinen

Research Group:
Medicinal Chemistry

Olli Pentikäinen
olli.pentikainen[at]utu.fi

Institute of Biomedicine,
University of Turku

Olli Pentikäinen

MedChem.fi

Autoimmune diseases, Basic research, Bioinformatics, Biomedicine, Cancer, Hit to lead, Inflammation, Inherited diseases, Lead optimization, Medicinal chemistry, Molecular modelling, Organic compounds, Pharmacology, Physico-chemical properties, Receptor, Screening, Signaling, Structural Biology, Synthetic chemistry

Picture of Mark S. Johnson

Research Group:
Structural bioinformatics for drug discovery and development

Mark S. Johnson
finmark54 at icloud dot com

Biochemistry,
Åbo Akademi University

Mark S. Johnson

Structural Bioinformatics Laboratory

Ageing-related diseases, Autoimmune diseases, Basic research, Biochemistry, Bioinformatics, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Chemical Physics, Computer Science, Diabetes, Drug target, Hit to lead, Inflammation, Inherited diseases, Lead optimization, Lung cancer, Medicinal chemistry, Metabolic diseases, Molecular modelling, Musculoskeletal disorders, Nucleic acids, Organic compounds, Pattern recognition, Personalized medicine, Physico-chemical properties, Preclinical development, Receptor, Signaling, Structural Biology, Surface area, Target discovery, X-ray crystallography